This month we will discuss how to align financial incentives, focus on important quality measures and redesign care in order to improve the health of populations. He will cover the basics and current state of the industry in its move to leverage value based payment systems; the evolution and challenges of quality metrics from strict clinical procedure outcomes to longer term care and ultimately health outcomes; and how care systems are being resigned to better promote population health.
Andrew Rein is a mission-driven senior executive with 20+ years of experience acquired in executive positions in the nation’s leading health care and public health organizations, and a proven ability to lead health system transformation and reform, population health, and organizational innovation. Andrew maximizes value by uniquely weaving strong performance and financial management, strategy development and implementation, policy priorities, and deep analytics. Continue reading March Section Meeting – Transition to Value-based Healthcare→
Proposals will be reviewed by the Committee for relevance, innovation, demonstrated application, and technical content. Priority will be given to new and unique approaches that have resulted in measurable improvements to organizational processes and customer satisfaction. The following is a list of suggested topics; however, you are not limited to the list. Feel free to send proposals in all areas that you feel are relevant to this year’s theme “Quality Takes More Than Luck.”
Some Proposed Focus Areas:
Leadership (Innovation, Change, Empowerment, Alignment to Goals)
This month’s section meeting will showcases several recent Lean Six Sigma projects, that the speaker facilitated, at local healthcare facilities where Lean Six Sigma Teams made processes faster, better and less expensive, while improving patient outcomes and satisfaction. The presentation will be interactive with comments and questions invited. Continue reading Section Meeting – Manufacturing Engineering Quality→
Bone marrow transplants are now routinely carried out worldwide to treat people with cancer and other disorders of the blood and immune system and are a prime example of a successful stem cell therapy. Stem cells from bone marrow, peripheral blood, or umbilical cord blood are used in transplantation procedures. From the first successful bone marrow transplant involving identical twins in the late 1950s to cutting edge research of today, the emphasis on quality has evolved and has led to the establishment of standards and regulations. This presentation will focus on a brief history of the development of bone marrow transplantation accreditation standards and regulations.
Many health care providers today receive a payment for each individual service they provide such as a physician visit, surgery, or blood test, and it matters to a lesser extent today whether these services directly improve the patient’s outcome. In other words, providers are paid primarily based on the volume of care they provide, rather than the value of care provided to patients. Emerging value-based reimbursement models increasingly require providers to prove that they’re meeting quality standards and benefitting patients while cutting costs. As a result, providers need actionable information to help them continually measure, monitor, and improve financial and quality performance. Furthermore, if they aren’t on track to meet quality standards, they need to be able to pinpoint root causes: Does performance differ by facility? Which providers are performing best and what can be learned from them?
To thrive in a value-based environment, health systems must develop the sophistication to understand their quality and cost structure in granular detail. Reducing every category of waste — e.g. waste that occurs when work isn’t standardized, waste that stems from unnecessary orders, waste that results from uncoordinated patient care — are all absolutely essential for improving margins.